Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Inspired Entertainment, Maintains $18 Price Target By Benzinga Newsdesk Today, 8:58 AM JMP Securities analyst Jordan Bender reiterates Inspired Entertainment (NASDAQ:INSE) with a Market Outperform and maintains $18 price target. INSE
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Booking Holdings, Maintains $2750 Price Target By Benzinga Newsdesk Today, 8:58 AM JMP Securities analyst Nicholas Jones reiterates Booking Holdings (NASDAQ:BKNG) with a Market Outperform and maintains $2750 price target. BKNG
Read More 1 minute read Analyst Color Analyst Ratings News Trading Ideas Jim Cramer Is Surprised No One Is Buying This ‘Very Good Bank’ Amid Crash By Shanthi Rexaline Today, 8:58 AM Shares of First Republic Bank (NYSE: FRC) were rebounding strongly in premarket on Tuesday. FRC
Read More 1 minute read Analyst Ratings News Price Target Canaccord Genuity Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $26 By Benzinga Newsdesk Today, 8:58 AM Canaccord Genuity analyst Sumant Kulkarni maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $24 to $26. ACAD
Read More 1 minute read Analyst Ratings News Price Target BMO Capital Maintains Outperform on Regeneron Pharmaceuticals, Raises Price Target to $1025 By Benzinga Newsdesk Today, 8:58 AM BMO Capital analyst Evan Kurtz maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and raises the price target from $1001 to $1025. REGN
Read More 1 minute read Analyst Ratings News Price Target Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $33 By Benzinga Newsdesk Today, 8:58 AM Cantor Fitzgerald analyst Charles Duncan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and raises the price target from $28 to $33. ACAD
Read More 1 minute read Analyst Ratings News Price Target Raymond James Maintains Strong Buy on Globe Life, Lowers Price Target to $138 By Benzinga Newsdesk Today, 8:58 AM Raymond James analyst Wilma Burdis maintains Globe Life (NYSE:GL) with a Strong Buy and lowers the price target from $141 to $138. GL
Read More 1 minute read Analyst Ratings Downgrades News Price Target Janney Montgomery Scott Downgrades Hancock Whitney to Neutral, Announces $44.5 Price Target By Benzinga Newsdesk Today, 8:58 AM Janney Montgomery Scott analyst Christopher Marinac downgrades Hancock Whitney (NASDAQ:HWC) from Buy to Neutral and announces $44.5 price target. HWC
Read More 1 minute read Analyst Ratings News Price Target Citigroup Maintains Buy on Luminar Technologies, Lowers Price Target to $19 By Benzinga Newsdesk Today, 8:58 AM Citigroup analyst Itay Michaeli maintains Luminar Technologies (NASDAQ:LAZR) with a Buy and lowers the price target from $20 to $19. LAZR
Read More 1 minute read Analyst Ratings News Price Target Citigroup Maintains Buy on Kinetik Holdings, Lowers Price Target to $34 By Benzinga Newsdesk Today, 8:58 AM Citigroup analyst Spiro Dounis maintains Kinetik Holdings (NYSE:KNTK) with a Buy and lowers the price target from $35 to $34. KNTK